212 related articles for article (PubMed ID: 33228421)
1. Unanticipated 30-day readmission following rectosigmoid resection at the time of cytoreductive surgery in patients with advanced stage ovarian cancer.
Sanders BE; Saharti S; Laus K; Bristow RE; Eskander RN
J Obstet Gynaecol; 2021 Aug; 41(6):956-961. PubMed ID: 33228421
[TBL] [Abstract][Full Text] [Related]
2. Predictive and Prognostic Implication of Bowel Resections During Primary Cytoreductive Surgery in Advanced Epithelial Ovarian Cancer.
Bartl T; Schwameis R; Stift A; Bachleitner-Hofmann T; Reinthaller A; Grimm C; Polterauer S
Int J Gynecol Cancer; 2018 Nov; 28(9):1664-1671. PubMed ID: 30371563
[TBL] [Abstract][Full Text] [Related]
3. Morbidity of rectosigmoid resection and primary anastomosis in patients undergoing primary cytoreductive surgery for advanced epithelial ovarian cancer.
Mourton SM; Temple LK; Abu-Rustum NR; Gemignani ML; Sonoda Y; Bochner BH; Barakat RR; Chi DS
Gynecol Oncol; 2005 Dec; 99(3):608-14. PubMed ID: 16153697
[TBL] [Abstract][Full Text] [Related]
4. Thirty-day unplanned hospital readmission in ovarian cancer patients undergoing primary or interval cytoreductive surgery: systematic literature review.
Clark RM; Rice LW; Del Carmen MG
Gynecol Oncol; 2018 Aug; 150(2):370-377. PubMed ID: 29929923
[TBL] [Abstract][Full Text] [Related]
5. Readmissions after ovarian cancer cytoreduction surgery: The first 30 days and beyond.
Mardock AL; Rudasill SE; Lai TS; Sanaiha Y; Wong DH; Sinno AK; Benharash P; Cohen JG
J Surg Oncol; 2020 Nov; 122(6):1199-1206. PubMed ID: 32700323
[TBL] [Abstract][Full Text] [Related]
6. PROFAST: A randomised trial implementing enhanced recovery after surgery for highcomplexity advanced ovarian cancer surgery.
Sánchez-Iglesias JL; Carbonell-Socias M; Pérez-Benavente MA; Monreal Clua S; Manrique-Muñoz S; García Gorriz M; Burgos-Peláez R; Segurola Gurrutxaga H; Pamies Serrano M; Pilar Gutiérrez-Barceló MD; Serrano-Castro S; Balcells-Farré MT; Pérez-Barragán C; Scaillet-Houberechts A; Cossio-Gil Y; Gil-Moreno A
Eur J Cancer; 2020 Sep; 136():149-158. PubMed ID: 32688208
[TBL] [Abstract][Full Text] [Related]
7. En-bloc pelvic resection with concomitant rectosigmoid colectomy and immediate anastomosis as part of primary cytoreductive surgery for patients with advanced ovarian cancer.
Yildirim Y; Ertas IE; Nayki U; Ulug P; Nayki C; Yilmaz I; Gultekin E; Dogan A; Aykas A; Ulug S; Ozdemir A; Solmaz U
Eur J Gynaecol Oncol; 2014; 35(4):400-7. PubMed ID: 25118481
[TBL] [Abstract][Full Text] [Related]
8. Risk factors and indications for 30-day readmission after primary surgery for epithelial ovarian cancer.
AlHilli M; Langstraat C; Tran C; Martin J; Weaver A; McGree M; Mariani A; Cliby W; Bakkum-Gamez J
Int J Gynecol Cancer; 2015 Feb; 25(2):193-202. PubMed ID: 25611896
[TBL] [Abstract][Full Text] [Related]
9. Morbidity of rectosigmoid resection in cytoreductive surgery for ovarian cancer. Risk factor analysis.
Fournier M; Huchon C; Ngo C; Bensaid C; Bats AS; Combe P; le FrèreBelda MA; Fournier L; Berger A; Lecuru F
Eur J Surg Oncol; 2018 Jun; 44(6):750-753. PubMed ID: 29580734
[TBL] [Abstract][Full Text] [Related]
10. Rectosigmoid resection morbidity in ovarian cancer cytoreductive surgery.
Usmani AS; Yasin I; Asif RB; Khalid N; Syed AA
J Pak Med Assoc; 2023 Jun; 73(6):1284-1287. PubMed ID: 37427631
[TBL] [Abstract][Full Text] [Related]
11. Factors Associated with Readmission After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Carcinomatosis.
Martin AS; Abbott DE; Hanseman D; Sussman JE; Kenkel A; Greiwe P; Saeed N; Ahmad SH; Sussman JJ; Ahmad SA
Ann Surg Oncol; 2016 Jun; 23(6):1941-7. PubMed ID: 26842489
[TBL] [Abstract][Full Text] [Related]
12. Total rectosigmoidectomy versus partial rectal resection in primary debulking surgery for advanced ovarian cancer.
Plotti F; Montera R; Aloisi A; Scaletta G; Capriglione S; Luvero D; De Cicco Nardone C; Basile S; Benedetti Panici P; Angioli R
Eur J Surg Oncol; 2016 Mar; 42(3):383-90. PubMed ID: 26725211
[TBL] [Abstract][Full Text] [Related]
13. National trends in bowel and upper abdominal procedures in ovarian cancer surgery.
Dottino JA; He W; Sun CC; Zhao H; Fu S; Rauh-Hain JA; Suidan RS; Lu KH; Giordano SH; Meyer LA
Int J Gynecol Cancer; 2020 Aug; 30(8):1195-1202. PubMed ID: 32616627
[TBL] [Abstract][Full Text] [Related]
14. Readmissions After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy: a US HIPEC Collaborative Study.
Lee TC; Wima K; Sussman JJ; Ahmad SA; Cloyd JM; Ahmed A; Fournier K; Lee AJ; Dineen S; Powers B; Veerapong J; Baumgartner JM; Clarke C; Mogal H; Zaidi MY; Maithel SK; Leiting J; Grotz T; Lambert L; Hendrix RJ; Abbott DE; Pokrzywa C; Blakely AM; Lee B; Johnston FM; Greer J; Patel SH
J Gastrointest Surg; 2020 Jan; 24(1):165-176. PubMed ID: 31745888
[TBL] [Abstract][Full Text] [Related]
15. Beyond post-operative readmissions: analysis of the impact of unplanned readmissions during primary treatment of advanced-stage epithelial ovarian cancer on long-term oncology outcome.
Huang D; Harrison R; Curtis E; Mirabadi N; Chen GY; Alexandridis R; Barroilhet L; Rose S; Hartenbach E; Al-Niami A
Int J Gynecol Cancer; 2023 May; 33(5):741-748. PubMed ID: 36808044
[TBL] [Abstract][Full Text] [Related]
16. Rectosigmoidectomy and Douglas Peritonectomy in the Management of Serosal Implants in Advanced-Stage Ovarian Cancer Surgery: Survival and Surgical Outcomes.
Erkilinç S; Karataşli V; Demir B; Çakir İ; Can B; Karadeniz T; Gökçü M; Sanci M
Int J Gynecol Cancer; 2018 Nov; 28(9):1699-1705. PubMed ID: 30371561
[TBL] [Abstract][Full Text] [Related]
17. Geriatric co-management leads to safely performed cytoreductive surgery in older women with advanced stage ovarian cancer treated at a tertiary care cancer center.
Filippova OT; Chi DS; Long Roche K; Sonoda Y; Zivanovic O; Gardner GJ; Tew WP; O'Cearbhaill R; Sarraf S; Sun SW; Alexander K; Korc-Grodzicki B; Shahrokni A
Gynecol Oncol; 2019 Jul; 154(1):77-82. PubMed ID: 31078241
[TBL] [Abstract][Full Text] [Related]
18. Rectosigmoid resection at the time of primary cytoreduction for advanced ovarian cancer. A multi-center analysis of surgical and oncological outcomes.
Peiretti M; Bristow RE; Zapardiel I; Gerardi M; Zanagnolo V; Biffi R; Landoni F; Bocciolone L; Aletti GD; Maggioni A
Gynecol Oncol; 2012 Aug; 126(2):220-3. PubMed ID: 22555105
[TBL] [Abstract][Full Text] [Related]
19. Rectosigmoid resection without colostomy during primary cytoreductive surgery for ovarian carcinoma.
Sonnendecker EW; Beale PG
Int Surg; 1989; 74(1):10-2. PubMed ID: 2707991
[TBL] [Abstract][Full Text] [Related]
20. Bowel resection or repair at the time of cytoreductive surgery for ovarian malignancy is associated with increased complication rate: An ACS-NSQIP study.
Bernard L; Boucher J; Helpman L
Gynecol Oncol; 2020 Sep; 158(3):597-602. PubMed ID: 32641239
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]